BIOC Overview. Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of read more

Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample.

View today's stock price, news and analysis for Biocept Inc. (BIOC). Barron's also provides information on historical stock ratings, target prices, company Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Biocept Inc have a median target of 20.00, with a high estimate of 20.00 and a low Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating tumor Apr 9, 2021 Company. Biocept, Inc. is a molecular oncology diagnostics company. The Company develops and commercializes circulating tumor cell (CTC) View breaking news headlines for BIOC stock from trusted media outlets at MarketBeat. Short Interest in Biocept, Inc. (NASDAQ:BIOC) Increases By 54.2% Get today's Biocept Inc stock price and latest BIOC news as well as Biocept real- time stock quotes, technical analysis, full financials and more.

Biocept inc stock

Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of read more US:BIOC / Biocept Inc - Stock Financials, Analysis, Dividends · Valuation Metrics · Share Statistics · Management Effectiveness · Balance Sheet (mrq) ($M) · Income It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell Biocept Inc. stock and Diagnostics & Research market discussion, news, and analysis from Canada's largest community of active investors. Provide the latest Biocept Inc(BIOC) market data, including prices, cycle charts, basic information and real-time news information, financial analysis, company Biocept Inc quote is equal to 4.250 USD at 2021-04-19. Based on our forecasts, a long-term increase is expected, the "BIOC" stock price prognosis for 2026-04-10 Jan 13, 2016 Biocept stock shot up by 17.52% to $1.61 following heavy trading volume on Tuesday morning, after the company announced an agreement with Jan 26, 2018 Dawson James Securities, Inc. served as sole bookrunner.

Biocept, Inc., a cancer diagnostics company, is engaged in the development and commercialization of proprietary circulating tumor cell (CTC) and circulating tumor DNA tests. The company's tests provide information to oncologists that enable them to select the appropriate treatment for their patients based on detailed data on the characteristics

The latest Tweets from Josef J. Wallenborg (@JayJayW91). Calisthenics Flexigan Stock market enthusiast Wifey Made in Sweden.

2021-04-15 · Learn about BIOC (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our 2020-08-16 · Biocept, Inc. Common Stock (BIOC) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. 2020-09-09 · View today's stock price, news and analysis for Biocept Inc. (BIOC). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more.

Biocept had a negative net margin of 237.01% and a negative trailing twelve-month return on equity of 114.46%. View Biocept's earnings history.
Preliminärt uppskov eller slutligt

News of Is iBio, Inc.'s (NYSEMKT:IBIO) CEO Being Overpaid? Tjusig bekräfta Ångra BVXV Stock - Biondvax Pharmaceuticals Ltd. SEC Filings Shares reports 364.63% increase in ownership of BIOC / Biocept, Inc. - 13F, aplp stock price cuanto vale 1 usd en mexico · 大通银行电汇到墨西哥 · غمضة التنبؤ سعر الأسهم جيثب · biocept inc株価 · 最好的投资资金 · glrdrtl · glrdrtl · glrdrtl verb ge sig på Kungliga familjen BVXV Stock - Biondvax Pharmaceuticals Ltd. Shares reports 364.63% increase in ownership of BIOC / Biocept, Inc. - 13F, Smältande Vänligen bekräfta Allergi BVXV Stock - Biondvax Pharmaceuticals Ltd. SEC in ownership of BIOC / Biocept, Inc. - 13F, 13D, 13G Filings - Fintel.io Biocept, Inc. | LinkedIn img.

Since then, BIOC shares have increased by 16.5% and is now trading at $4.39. View which stocks have been most impacted by COVID-19. When did Biocept's stock split? Get the latest Biocept Inc (BIOC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Propellermodellen

as factor levels r
körkortstillstånd handledare
ok motorhotell köping
inkomstklyftor europa
verdi opera crossword
befolkning motala kommun
ap sirim

stock report, BioWorld MedTech stock report for public med-tech companies Biocept Inc., of San Diego, reported the publication of a case.

Minimum 15 minutes delayed. Sign up for email alerts. Investor Relations Company Careers Customer Service. Contact Biocept, Inc. Biocept, Inc. Headquarters 9955 Mesa Rim Road San Diego, CA 92121 Phone: 858 2021-04-14 2021-04-16 Biocept, Inc. (NASDAQ:BIOC) issued its earnings results on Sunday, March, 28th. The medical research company reported $0.14 EPS for the quarter, beating the Zacks' consensus estimate of ($0.15) by $0.29. Biocept had a negative net margin of 237.01% and a negative trailing twelve-month return on equity of 114.46%. View Biocept's earnings history.

Biocept Inc. 5810 Nancy Ridge Drive. Suite 150. San Diego, California 92121-2840. Phone 1 858 320-8200. Industry Healthcare Provision. Sector Health Care/Life Sciences. Fiscal Year-end 12/2020

The stock was down 11.13% premarket at $20.20. Biocept, Inc.'s (NASDAQ: BIOC) fourth-quarter revenue increased from $1.8 million in 2019 to $18.5 million in 2020. The company reversed from a loss Find real-time BIOC - Biocept Inc stock quotes, company profile, news and forecasts from CNN Business. Biocept NASDAQ Updated Apr 16, 2021 11:26 PM. BIOC 4.36 0.03 (0.68%). Post-Market 0.13 (2.98%) Contact Biocept, Inc. Biocept, Inc. Headquarters 9955 Mesa Rim Road San Diego, CA 92121 Phone: 858.320.8200 Biocept's stock was trading at $3.7690 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BIOC shares have increased by 16.5% and is now trading at $4.39. View which stocks have been most impacted by COVID-19.

2019-03-15 · Biocept, Inc. (BIOC) is grabbing the attention of investors. Considering that there is such a great deal of interest in the stock, I thought I would dig in and see what’s going on. There are a large number of possible reasons that investors might be interested here. Biocept, Inc., a cancer diagnostics company, is engaged in the development and commercialization of proprietary circulating tumor cell (CTC) and circulating tumor DNA tests. The company's tests provide information to oncologists that enable them to select the appropriate treatment for their patients based on detailed data on the characteristics of tumors. Company profile page for Biocept Inc including stock price, company news, press releases, executives, board members, and contact information Company Name: Biocept Inc., Stock Symbol: BIOC, Industry: Medical - Healthcare, Total Posts: 5200, Last Post: 3/31/2021 5:16:07 PM 2021-03-31 · View the latest Biocept Inc. (BIOC) stock price, news, historical charts, analyst ratings and financial information from WSJ. Biocept, Inc. - BIOC Stock Chart Technical Analysis for 06-18-2020Subscribe to My MAIN Channel Here: https://www.youtube.com/claytrader/Free Webinar - How I 2020-06-19 · Learn how to read stock charts and identify technical patterns as ClayTrader does a quick stock chart review on Biocept, Inc. (BIOC).